Modest weight loss does not increase plasma adiponectin levels: effects of weight loss on C-reactive protein and DNA damage

Nutrition Research

Volumn 26, Issue 8, 2006, Pages 391-396

  Shin, Min Jeong ^a   Yoen Kim, Oh ^b   Koh, Soo Jeong ^b   Chae, Jey Sook ^b   Kim, Ji Young ^b   Jang, Yangsoo ^a,b   Lee, Jong Ho ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Adiponectin; C reactive protein; DNA damage; Obese subjects; Weight loss

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; DNA; GLUCOSE; INSULIN; LIPID;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY WEIGHT; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INTERVENTION STUDY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; METABOLIC PARAMETERS; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WEIGHT CHANGE; WEIGHT REDUCTION;

EID: 33748757227     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2006.06.021     Document Type: Article

References (40)

1. Klein S. Outcome success in obesity. Obes Res 9 (2001) 354S-358S
2. Wadden T.A., Anderson D.A., and Foster G.D. Two-year changes in lipids and lipoproteins associated with the maintenance of a 5% to 10% reduction in initial weight: some findings and some questions. Obes Res 7 (1999) 170-178
3. Case C.C., Jones P.H., Nelson K., O'Brian S.E., and Ballantyne C.M. Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab 4 (2002) 407-414
4. Tchernof A., Nolan A., Sites C.K., Ades P.A., and Poehlman E.T. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 105 (2002) 564-569
5. Bastard J.P., Jardel C., Bruckert E., Blondy P., Capeau J., Laville M., et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85 (2000) 3338-3342
6. Hu E., Liang P., and Spiegelman B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271 (1996) 10697-10703
7. Yamauchi T., Kamon J., Waki H., Imai Y., Shimozawa N., Hioki K., et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278 (2003) 2461-2468
8. Okamoto Y., Kihara S., Ouchi N., Nishida M., Arita Y., Kumada M., et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106 (2002) 2767-2770
9. Chandran M., Ciaraldi T., Philips S.A., and Henry R.R. Adiponectin: more than just another fat cell hormone?. Diabetes Care 26 (2003) 2442-2450
10. Xydakis A.M., Case C.C., Jones P.H., Hoogeveen R.C., Liu M.Y., Smith S.O., et al. Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab 89 (2004) 2697-2703
11. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20 (2000) 1595-1599
12. Yang W.S., Lee W.J., Funahashi T., Tanaka S., Matsuzawa Y., Chao C.L., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86 (2001) 3815-3819
13. Bruun J.M., Lihn A.S., Verdich C., Pedersen S.B., Toubro S., Astrup A., et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 285 (2003) E527-E533
14. Fruebis J., Tsao T.S., and Javorschi S. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci 98 (2001) 2005-2010
15. Steering Committee. Assessment diagnosis. The Asia-Pacific perspective: redefining obesity and its treatment (2000), Health Communications Australia Pty Limited publication 15-21
16. Friedewald W.T., Levy R.T., and Frederickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 18 (1972) 449-502
17. Green M.H., Low J.E., Haarcourt S.A., Akinluyi P., Rowe T., Cole J., et al. UV-C sensitivity of unstimulated and stimulated human lymphocytes from normal and xeroderma pigmentosum donors in the comet assay: a potential diagnostic technique. Mutat Res 279 (1992) 137-144
18. Eda S., Kaufmann J., Roos W., and Pohl S. Development of a new microparticle-enhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range. J Clin Lab Anal 12 (1998) 137-144
19. Cesari M., Penninx B.W., Newman A.B., Kritchevsky S.B., Nicklas B.J., Sutton-Tyrrell K., et al. Inflammatory markers and onset of cardiovascular events: results from the health ABC study. Circulation 108 (2003) 2317-2322
20. Koukkunen H., Penttila K., Kemppainen A., Halinen M., Penttila I., Rantanen T., et al. C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med 33 (2001) 37-47
21. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
22. Festa A., D'Agostino R., Howard G., Mykknen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome. The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
23. Bacci S., Vigna C., Menzachi C., Fanelli R., Ercolino T., Mario U., et al. The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care 27 (2004) 2015-2020
24. Menzaghi C., Ercolino T., Di Paola R., Berg A.H., Warram J.H., Scherer P.E., et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51 (2002) 2306-2312
25. Huang K.C., Lue B.H., Yen R.F., Shen C.G., Ho S.R., Tai T.Y., et al. Plasma adiponectin levels and metabolic factors in nondiabetic adolescents. Obes Res 12 (2004) 119-124
26. Iwashima Y., Katsuya T., Ishikawa K., Ouchi N., Ohishi M., Sugimoto K., et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43 (2004) 1318-1323
27. Haluzik M., Parizkova J., and Haluzik M.M. Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res 53 (2004) 123-129
28. Faraj M., Havel P.J., Phelis S., Blank D., Sniderman A.D., and Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 88 (2003) 1594-1602
29. Mousavinasab F., Tahtinen T., Jokelainen J., Koskela P., Vanhala M., Oikarinen J., et al. Lack of increase of serum adiponectin concentrations with a moderate weight loss during six months on a high-caloric diet in military service among a young male Finnish population. Endocrine 26 (2005) 65-70
30. Abbasi F., Lamendola C., McLaughlin T., Hayden J., Reaven G.M., and Reaven P.D. Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women. Metabolism 53 (2004) 280-283
31. Wolfe B.E., Jimerson D.C., Orlova C., and Mantzoros C.S. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin Endocrinol 61 (2004) 332-338
32. Olefsky J., Reaven G.M., and Farquhar J.W. Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects. J Clin Invest 53 (1974) 64-76
33. Jones C.N., Abbasi F., Carantoni M., Polonsky K.S., and Preaven G.M. Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. Am J Physiol Endocrinol Metab 278 (2000) E501-E508
34. Heilbronn L.K., de Jonge L., Frisard M.I., DeLany J.P., Larson-Meyer D.E., Rood J., et al. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA 295 (2006) 1539-1548
35. Sohal R.S., Agarwal S., Candas M., Forster M.J., and Lal H. Effect of age and calorie restriction on DNA oxidative damage in different tissues of C57BL/6 mice. Mech Ageing Dev 76 (1994) 215-224
36. Hamilton M.L., Remmen H.V., Drake J.A., Yang H., Guo Z.M., Kewitt K., et al. Does oxidative damage to DNA increase with age?. Proc Natl Acad Sci U S A 98 (2001) 10469-10474
37. Chung M.H., Kasai H., Nishimura S., and Yu B.P. Protection of DNA damage by dietary restriction. Free Radic Biol Med 12 (1994) 523-525
38. Raffoul J.J., Guo Z., Soofi A., and Heydari A.R. Caloric restriction and genomic stability. J Nutr Health Aging 3 (1999) 102-110
39. Djuric Z., Lu M.H., Lewis S.M., Luongo D.A., Chen X.W., Heilbrum L.K., et al. Oxidative DNA damage in rats fed low-fat, high-fat or calorie-restricted diets. Toxicol Appl Pharmacol 115 (1992) 156-160
40. Feuers R.J., Duffy P.H., Leakey J.A., Turturro A., Mittelstaedt R.A., and Hart R.W. Effect of chronic caloric restriction on hepatic enzymes of intermediary metabolism in the male Fischer 344 rat. Mech Ageing Dev 48 (1989) 179-189